Dr. Michael Berelowitz
Director
Haematology
Kamada
Israel
Biography
Dr. Michael Berelowitz has served on our Board of Directors since July 2015. Dr. Berelowitz currently serves as a biopharmaceuticals consultant, and is a member of several Boards of Directors or Scientific Advisory Boards, including, Oramed Pharmaceuticals (NASDAQ: ORMP), Recro Pharma, Inc. (NASDAQ: REPH) and DIR Technologies. Dr. Berelowitz has more than 40 years' experience in clinical development and academic research, including 15 years of experience in pharmaceutical development with Pfizer, Inc. where he served as a Senior Vice President and Head of Clinical Development and Medical Affairs in the Specialty Care Business Unit. Prior to that, Dr. Berelowitz spent a number of years in academia and has held several appointments at the University of Chicago, University of Cincinnati College of Medicine, SUNY at StonyBrook and, most recently, Mount Sinai School of Medicine. In Addition, Dr. Berelowitz has served on the Board of Directors of the American Diabetes Association, the Endocrine Fellows Foundation, the Clinical Initiatives Committee of the Endocrine Society and has chaired the Task Force on Research of the New York State Council on Diabetes.
Research Interest
Dr. Berelowitz completed his medical degree, residency training in Pathology, Nuclear Medicine and Internal Medicine and fellowship training in Endocrinology and Metabolism at the University of Cape Town.
